Director/PDMR Shareholding

RNS Number : 0242F
Phosphagenics Limited
03 October 2008

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R (1).

(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23
and 24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Please complete all relevant boxes should in block capital letters.

1. Name of the issuer
PHOSPHAGENICS LIMITED
2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
3. Name of director
JOHN MILLS (Professor)
4. State whether notification relates to a person connected with a director named in 3 and identify the connected person
The transaction / event relates to a purchase on 1 October and 2 October 2008 of 100,000 ordinary fully paid Phosphagenics Limited
shares made on-market in the normal course of trading of the Australian Stock Exchange on behalf of the Portsea Superannuation Fund
registered in the names of Professor John Mills & Professor Suzanne Mary Crowe< Portsea Superannuation Fund>. A Fund in which Professor
Mills is a beneficiary.
5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a
non-beneficial interest
Refer to the text of 4 above
6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares
Ordinary Fully Paid Shares
7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
Professor John Mills & Professor Suzanne Mary Crowe: 164,667 ordinary shares (unchanged)
Professor John Mills & Professor Suzanne Mary Crowe < Portsea Superannuation Fund>: 312,000 ordinary shares as varied by the 100,000
purchased as noted in item 4 above)
8 State the nature of the transaction
Purchase on-market as described in 4 above
9. Number of shares, debentures or financial instruments relating to shares acquired
100,000 ordinary shares on behalf of the Portsea Superannuation Fund
10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
0.0284 per cent (Total number of Issued Ordinary Shares: 663,542,406 shares)
11. Number of shares, debentures or financial instruments relating to shares disposed
N/A
12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N/A
13. Price per share or value of transaction
A$0.07
14. Date and place of transaction
1 October and 2 October 2008 as traded in the normal course of trading of the official lists of the Australian Stock Exchange
15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken
into account when calculating percentage)
476,667 ordinary shares being 0.0718 per cent of total Issued Ordinary Shares 663,542,400 shares.
16. Date issuer informed of transaction
Professor Mills informed the Company after close of trading on Thursday
2 October 2008 of the completion of the order for the 100,000 shares.
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17 Date of grant
N/A
18. Period during which or date on which it can be exercised
N/A
19. Total amount paid (if any) for grant of the option
N/A
20. Description of shares or debentures involved (class and number)
N/A
21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
N/A
22. Total number of shares or debentures over which options held following notification
N/A
23. Any additional information
NIL
24. Name of contact and telephone number for queries
Mourice Garbutt, Company Secretary, Phosphagenics Limited + 613 9605 5917
Name and signature of duly authorised officer of issuer responsible for making notification
Mourice Garbutt, Company Secretary, Phosphagenics Limited

Date of notification
3 October 2008
END

This information is provided by RNS
The company news service from the London Stock Exchange

END

RDSFSESADSASEES

Phosphagen. (LSE:PSG)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024